Voloridge Investment Management, LLC Kodiak Sciences Inc. Transaction History

Voloridge Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.05 $893,337 - $1.1 Million	-137,015 Reduced 45.72%	162,662 $1.16 Million
Q3 2022 Nov 14, 2022	SELL	$7.57 - $12.5 $1.97 Million - $3.26 Million	-260,715 Reduced 46.52%	299,677 $2.32 Million
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.48 $772,364 - $1.45 Million	153,247 Added 37.64%	560,392 $4.28 Million
Q1 2022 May 16, 2022	BUY	$7.09 - $89.45 $2.78 Million - $35.1 Million	392,460 Added 2672.52%	407,145 $3.14 Million
Q4 2021 Feb 14, 2022	SELL	$80.85 - $128.49 $1.32 Million - $2.1 Million	-16,320 Reduced 52.64%	14,685 $1.25 Million
Q3 2021 Nov 15, 2021	SELL	$81.97 - $106.94 $5.88 Million - $7.67 Million	-71,721 Reduced 69.82%	31,005 $2.98 Million
Q2 2021 Aug 16, 2021	SELL	$77.2 - $126.54 $1.21 Million - $1.99 Million	-15,691 Reduced 13.25%	102,726 $9.55 Million
Q1 2021 May 17, 2021	BUY	$110.45 - $164.47 $12 Million - $17.8 Million	108,411 Added 1083.46%	118,417 $13.4 Million
Q4 2020 Feb 16, 2021	BUY	$60.78 - $154.03 $608,164 - $1.54 Million	10,006 New	10,006 $1.47 Million
Q2 2020 Aug 14, 2020	SELL	$42.74 - $66.25 $294,777 - $456,926	-6,897 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$38.18 - $73.95 $263,327 - $510,033	6,897 New	6,897 $329,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $417M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.